Blake Dark

Senior Partner Newmarket Strategy. Former Commercial Medicines Director - NHSE. Medicines and healthcare innovation and Fulham FC mostly. All views my own.

[Blake Dark @blakeydark]

The medicines & conditions can be a bit tricky to say😁… but the simple fact is that the NHS is securing innovative treatments for frontline staff to offer first class care to people across the country. I was delighted to share a few stories at the NHS Board meeting last week

[James O'Shaughnessy @jamesosh]

My review of UK commercial clinical trials is published today: https://t.co/i1oUlgRb1K. I'm incredibly grateful to the doctors, nurses, researchers, companies, public servants, charities and patients who contributed.

[Blake Dark @blakeydark]

I'm delighted that pembrolizumab with chemotherapy will be available to women with triple negative breast cancer following another NHS deal. This will benefit up to 1,600 patients each year – like NHS nurse, Lauren who is now almost five years cancer free. https://t.co/KppscYwSxE

[Blake Dark @blakeydark]

@tomjgreatrex @sportingintel @uglygame @peterrutzler @TheAthletic I’m also interested in the name of the 3rd party that conducted the due-diligence and their ongoing role with FFC.

[Blake Dark @blakeydark]

@MotherhoodvsCF Thank you Carlie - it is truly something I am proud to have been a part of. Take care .

[Blake Dark @blakeydark]

@pmrleahy @NHSEngland @WhichUK It was a pleasure to have you as part of the team. What a difference you made! I am delighted that you look back upon what you/the team achieved and are rightly proud! Best wishes and stay in touch.

[Blake Dark @blakeydark]

Today, @NHSEngland in partnership with @NICEComms, launch the Innovative Medicines Fund - the Fund will continue NHS momentum as an adopter of medical innovation through agreements that also safeguard value for taxpayers. https://t.co/cOs67nKXt9

[NHS England @NHSEngland]

Hundreds of people with the most common form of an aggressive lung cancer could survive twice as long, thanks to a drug now available on the NHS.

The drug, durvalumab, can double the overall time someone can survive from two and a half to five years. 👉 https://t.co/kYoIwSYjk8

[Blake Dark @blakeydark]

With partners @NICEComms and @DHSCgovuk we’ve taken a big step with our #AMR pilot where the UK is really ‘punching above its weight’ to provide a model for health systems Worldwide. https://t.co/pD1ex1cR1p

[NHS England @NHSEngland]

A revolutionary tumour-stopping drug for lung cancer will be made available to anyone who is eligible, thanks to a new deal announced today.

Read how hundreds more patients will now be able to receive this first-of-its-kind treatment. ➡️ https://t.co/BH1X5foNF2

[Blake Dark @blakeydark]

I am pleased that dostarlimab will be available from today via the Cancer Drugs Fund. This is another example of where the CDF will fast-track the most clinically promising treatments to patients whilst further data is collected, which is great news for patients and clinicians

[NHS England @NHSEngland]

A 30-minute treatment, the first of its kind for advanced womb cancer, is being rolled out for women across England.

Find out how patients with advanced or recurrent endometrial cancer will be offered this life-extending drug, called dostarlimab. ➡️ https://t.co/fq6M2zmvPn

[Blake Dark @blakeydark]

Great news for NHS patients - thanks to the @NHSEngland, @_RocheUK, @NICEComms and @MHRAgovuk working together, the promising lung cancer drug, atezolizumab can be fast-tracked to people with #NSCLC following its licensing through #ProjectOrbis

[NHS England @NHSEngland]

Thousands of lung cancer patients in England will be fast-tracked a ground-breaking new drug, atezolizumab, which can significantly reduce the risk of cancer returning.

Read more about the cutting-edge treatment. ➡️ https://t.co/N82ui2Y5w1

[Blake Dark @blakeydark]

An important call to arms on AMR. Read more about what NHS England and partners are doing to show leadership in this area https://t.co/BApwjyaz72 #TogetherForAntibiotics

[Prof. Dame Sally Davies @UKAMREnvoy]

The 'silent pandemic' is not silent anymore.

New data, published in today’s #Lancet, show the true global cost of #AMR.

We must use these data as a warning signal to spur on action at every level.

#AMRSOS 👉 https://t.co/PsGjirim7N

[Blake Dark @blakeydark]

@PKUFamily Thank you @PKUFamily we wish you a very merry Christmas too. Take care

[Blake Dark @blakeydark]

Delighted to announce @NHSEngland has agreed a deal with @Teva_UK to secure a generic version of the drug sapropterin for #PKU patients of all ages in England.
After an active 12 months, this latest deal paves the way for 100s of people to benefit from treatment in the New Year

[Blake Dark @blakeydark]

Our NHS commercial medicines deals put innovative treatments into the hands of amazing front-line staff like Dr Elizabeth Wraige. It’s great to hear how this third NHS agreement for new SMA drugs in less than three years is enabling such leaps in patient care & treatment

[NHS England @NHSEngland]

‘This is fantastic news for all the families and children affected by this condition.’

Dr Elizabeth Wraige, Consultant Paediatric Neurologist, explains more about what the drug Risdiplam means for patients with spinal muscular atrophy. Read more. ➡️ https://t.co/dEadm7VoKs

[Blake Dark @blakeydark]

Excellent news that patients with sickle cell disease will be able to access the first new drug in over 20 years, crizanlizumab. More from @AmandaPritchard here:

[NHS England @NHSEngland]

The first sickle cell treatment in over 20 years will be available to thousands of patients thanks to a new deal announced today.

The revolutionary treatment will help save lives, improve quality of life and reduce A&E trips by almost half. https://t.co/NbsQLqx5Gd

🎥: @BBCNews

[Blake Dark @blakeydark]

Fantastic achievement from the Commercial Medicines Unit who have won the 'Procurement Team of the Year Award’ at the @GOAwardsNews. This award reflects the hard work undertaken to ensure patients with Haemophilia A can access treatments whilst safeguarding the NHS budget

[Amanda Pritchard @AmandaPritchard]

The NHS has today begun the world's largest trial of a new blood test that detects more than 50 types of cancer before symptoms appear. By finding cancer early, we have the best chance of treating it and giving people the best possible chance of survival.

[Michelle Mitchell @Michelle_CRUK]

This is one of the most exciting breakthroughs in lung cancer in 20 years.

Sotorasib is a precision treatment – now approved in England, but it's a milestone 40 years in the making, with research by @CR_UK and many others.
https://t.co/bBEtMyCtS1